1.0% C31G SAVVY vaginal gel

DRUG2 trials

Sponsors

Biosyn

Conditions

HIV Infections

Phase 3

Trial of SAVVY and HIV in Ghana

BiosynHIV Infections

Start: 2004-01-31Target: 2142Updated: 2005-09-08

Trial of SAVVY Vaginal Gel and HIV in Nigeria

BiosynHIV Infections

Start: 2004-09-30Target: 2142Updated: 2005-09-26

Related Papers

SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.

2007-12-19140 citations